B. DEBELEÇ BÜTÜNER Et Al. , "Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis," STEROIDS , vol.135, pp.9-20, 2018
DEBELEÇ BÜTÜNER, B. Et Al. 2018. Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis. STEROIDS , vol.135 , 9-20.
DEBELEÇ BÜTÜNER, B., Ozturk, M. B., Tag, O., Akgun, I. H., YETİK ANACAK, G. Y., Bedir, E., ... KORKMAZ, K. S.(2018). Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis. STEROIDS , vol.135, 9-20.
DEBELEÇ BÜTÜNER, BİLGE Et Al. "Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis," STEROIDS , vol.135, 9-20, 2018
DEBELEÇ BÜTÜNER, BİLGE D. Et Al. "Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis." STEROIDS , vol.135, pp.9-20, 2018
DEBELEÇ BÜTÜNER, B. Et Al. (2018) . "Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis." STEROIDS , vol.135, pp.9-20.
@article{article, author={BİLGE DEBELEÇ BÜTÜNER Et Al. }, title={Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis}, journal={STEROIDS}, year=2018, pages={9-20} }